Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
AMC Global Media Inc. announced it will report its second quarter 2026 financial results on July 30, 2026, followed by a conference call to discuss these results. The company operates multiple well-known streaming services and cable networks catering to diverse global audiences.
Darren M. Rebelez, President and Chief Executive Officer of Casey’s General Stores Inc. (NASDAQ: CASY), executed a sale of 18,522 shares of the company’s common stock on July 7, 2026. The transaction generated proceeds totaling approximately $15,227,687, with shares sold at prices ranging from $793.02 to $815.76 per share. These prices represent we…
Cabot Corporation announced it will release its operating results for the third quarter of fiscal 2026 on August 3, 2026, followed by a conference call on August 4. The company is a leader in specialty chemicals and materials, reporting from Boston, Massachusetts.
Nurix Therapeutics reported strong corporate and financial updates for Q2 2026, including a global collaboration with Roche for bexobrutideg with potential payments up to $2.3 billion, positive clinical data supporting bexobrutideg's efficacy in chronic lymphocytic leukemia (CLL), and plans to expand development into immunology and neurology indica…
Denali Therapeutics' CEO Dr. Ryan Watts will deliver the opening address at the 2026 Alzheimer's Association International Conference to showcase breakthroughs in their proprietary TransportVehicle™ platform, enabling biologic drugs to cross the blood-brain barrier. The company is advancing investigational therapies targeting tau and amyloid beta f…
20/20 BioLabs presented its strategy during an investor webinar to advance OneTest™ for Cancer as an affordable multi-cancer early detection blood test targeting Medicare reimbursement under new federal legislation starting 2028. The company emphasized its differentiating serial biomarker tracking technology, real-world evidence generation from hig…
MKS Inc., a global technology provider serving semiconductor manufacturing and specialty industrial applications, has been named one of America’s Best Companies for 2026 by Time and Statista. This marks the second consecutive year MKS received this recognition, which evaluates companies based on employee satisfaction, financial success, and sustain…
Tilray Medical, a division of Tilray Brands, announced the commercial launch of its medical cannabis product, Tilray Oral Solution CBD100, in Panama through partnership with local pharmacy chain Farmacias Arrocha. This launch marks a key step in Tilray's global expansion and advances patient access to regulated, pharmaceutical-quality cannabinoid m…
KPMG's UK business has proposed a 10% reduction across its central support teams as part of integration activity following a 2024 merger with its Switzerland operations. The move, which could affect roughly 200 roles, is subject to consultation under UK employment law. The firm says the proposals aim to remove duplication, leverage technology inves…
AstraZeneca plunged more than 10% intraday after headlines tied the stock to a heart-disease trial setback. That knee-jerk move created a tradable opportunity: the company’s scale, pipeline depth, and cash flow profile cushion the hit. This trade plan targets a mean-reversion bounce over the next 45 trading days while keeping a tight stop to respec…
Bank of America Global Research pared back short-term commodity forecasts and lowered valuations across North American metals and mining names, but singled out three companies as top picks for 2026: Cameco (CCJ), Freeport-McMoRan (FCX) and Pan American Silver (PAAS). The firm reduced numerous price objectives and 2026 estimates across its coverage …
A new SemiAnalysis report concludes that Meta Superintelligence (MSL) has vaulted into a position from which it could overtake Google in frontier AI within six months. The boutique research firm highlights Meta's inward-focused data strategy, the redeployment of 3,000 engineers to build an in-house reinforcement learning environment factory, the la…
Ukrainian President Volodymyr Zelenskiy said a Russian strike hit an ammunition warehouse in Vyshneve on the western outskirts of Kyiv, triggering massive secondary explosions on July 6 that killed 10 people and damaged hundreds of homes. A criminal investigation has been opened and officials at state arms producer Ukroboronprom, which owned the si…
Cosmos Health Inc. announced additional repurchases of 80,000 shares under its ongoing buyback program, totaling 4.14 million shares at an average price of about $0.2503 each. This move underscores the company's belief that the stock is trading below its intrinsic value. The open market repurchase program, with a budget of up to $5 million, will co…
Duolingo's selloff has priced in slower near-term monetization but left a resilient, hyper-engaged user base, a clean balance sheet, and healthy free cash flow. At $130.25, the stock offers a reasonable entry for a long trade targeting a re-rating as user-first strategy returns to monetization, with defined stops and a clear horizon.
Northern Trust (NTRS) looks positioned to report a solid Q2 driven by rising assets under custody, higher fee income and improved net interest income dynamics seen across custody banks. The stock trades around $183.58 with a mid-teens upside to our $200 target and a risk-managed stop below $172.
Camtek (CAMT) has premium multiples for a reason: a sticky niche in advanced packaging and HBM inspection, a recent beat-and-raise quarter and a still-large addressable-market runway. Valuation is rich, momentum is choppy and short interest keeps the stock volatile. Recommended action: buy on a tactical pullback with strict risk controls and a 180-…
Federal Reserve Chairman Kevin Warsh has appointed leaders for five independent task forces to conduct a top-to-bottom review of the central bank's monetary policy operations. While reaffirming the Fed's dual mandate - price stability and maximum employment - Warsh said the economy's rapid evolution requires updated tools, data and communication st…
The U.S. Senate returns for a four-week legislative period expected to take up defense and other national security measures while Republican Senator Mitch McConnell remains hospitalized with undisclosed health problems. McConnell, 84, who chairs the Senate Rules Committee and a defense appropriations panel, has been absent since mid-June. His offic…
Federal Reserve Chair Kevin Warsh has appointed a diverse set of economists, former central bankers and private-sector figures to lead five independent task forces that will review the Fed's operations. The groups, announced after Warsh's first policy meeting on June 16-17 and formally named on Thursday, will examine technical matters including bal…
The United Nations reported that Russian aerial strikes killed at least 265 civilians and injured 1,816 in Ukraine during June, marking the largest combined civilian casualty total since the opening months after Moscow launched its full-scale invasion in February 2022. U.N. officials warned the trend may be continuing into July, and finalized figur…
Most bond strategists surveyed remain of the view that shorter-dated U.S. Treasury yields will retreat over coming months even after a fresh escalation in the U.S.-Israeli war with Iran sent oil prices sharply higher and pushed benchmark yields to multi-week peaks. While longer-dated yields climbed and some policymakers warned inflation risks persi…
Goldman Sachs has revised its personal trading policy to prohibit employees from participating in most prediction-market trading. The rule excludes only sports and entertainment wagers and explicitly bans event contracts tied to specific companies, including Goldman Sachs itself, as well as bets on elections and financial market performance. Violat…
Palantir trades with a market value north of $300 billion while sporting a trailing P/E in the ~140-150x range and EV/FCF near 117x. That pricing assumes years of flawless execution and sustained hyper-growth. This trade idea outlines a mid-term short with entry at $129.00, a stop at $150.00, and a primary target of $100.00 over roughly 45 trading …
Riley Exploration Permian (REPX) has moved from stability to visible improvement: improving cash flow, a sustainable dividend and conservative leverage create a high-probability trade setup. We outline a mid-term (45 trading days) long with precise entry, stop and target levels and a balanced view of the key catalysts and risks.
